文献速递胃肠外科围术期管理与 ERAS

机器人与腹腔镜腹会阴切除术治疗肛管癌:NCDB 数据提示优于开放手术

Robotic and laparoscopic abdominoperineal resections for anal cancer may improve outcomes compared with open surgery: insights from the National Cancer Database.
PubMed 文献 · Surg Endosc · 2026-06-02

基于美国国家癌症数据库(NCDB)2010–2022 年 3756 例肛管癌腹会阴切除术(APR)患者,比较机器人、腹腔镜与开放手术的围术期结局和生存。微创组 30 天和 90 天死亡率更低、切缘阳性更少、住院更短;

要点

  • 肛管癌 APR 中机器人占比后期显著上升,开放手术下降。
  • 微创 APR 围术期死亡率、切缘阳性率和住院时间均优于开放。
  • 校正混杂后开放 APR 死亡风险高于机器人,腹腔镜与机器人相当。

核心结论

  • 肛管癌微创 APR 随时间增加,与更短住院、更低围术期死亡率、更少切缘阳性及更好生存相关。
  • 研究支持经适当选择的肛管癌患者优先采用腹腔镜或机器人 APR。

研究设计与样本

  • 基于美国国家癌症数据库(NCDB)2010–2022 年肛管癌 APR 患者的回顾性队列研究,共 3756 例。
  • 按初始手术方式分为机器人(831 例)、腹腔镜(723 例)和开放(2202 例)三组,近似意向性治疗分析。
  • 研究期分为早期(2010–2016)和后期(2017–2022)以评估时间趋势,比较人口学、肿瘤特征和围术期结局。
  • 主要终点包括 30 天和 90 天死亡率、住院时间、切缘阳性和总生存。

主要发现

  • 机器人 APR 在后期显著增加(33.3% vs 13.2%,P<0.001),开放 APR 下降(48.2% vs 66.9%),腹腔镜稳定(18.5% vs 19.9%)。
  • 30 天死亡率:机器人 1.2%、腹腔镜 1.7%、开放 2.2%(P<0.001)。
  • 90 天死亡率:机器人 3.2%、腹腔镜 3.6%、开放 4.9%(P<0.001)。
  • 切缘阳性率:机器人 14.4%、腹腔镜 14.1%、开放 17.8%(P<0.001)。
  • 中位住院时间:机器人 5 天、腹腔镜 6 天、开放 8 天(P<0.001);5 年总生存分别为 56%、54%、49%。

关键数值与推荐

  • 腹腔镜与机器人 APR 的生存相当。

临床怎么用

  • 对经适当选择的肛管癌患者,可优先考虑腹腔镜或机器人 APR 以改善围术期结局。
  • 开放 APR 仍可作为备选,但需权衡其较高的死亡风险和切缘阳性率。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abdominoperineal resection (APR) is an important treatment option for anal cancer patients with incomplete response or recurrence after chemoradiation, yet the frequency and effectiveness of minimally invasive surgery (MIS) remain poorly described. This study examines trends and outcomes of robotic, laparoscopic, and open APR using the National Cancer Database (NCDB). METHODS: Patients undergoing APR for anal cancer in the NCDB (2010-2022) were categorized by surgical approach based on the initial operative technique, approximating an intention-to-treat framework. The study period was divided into early (2010-2016) and late (2017-2022) eras to assess temporal trends. Demographics, tumor characteristics, and perioperative outcomes were compared. Primary endpoints included 30- and 90-day mortality, length of stay, margin positivity, and overall survival. RESULTS: Among 3756 patients (831 robotic, 723 laparoscopic, 2202 open), baseline characteristics were similar across approaches. Robotic APR increased significantly in the late era (33.3% vs 13.2%, p < 0.001), whereas open APR declined (48.2% vs 66.9%) and laparoscopic APR remained stable (18.5% vs 19.9%). MIS approaches demonstrated lower 30-day mortality (1.2% robotic vs 1.7% laparoscopic vs 2.2% open, p < 0.001), lower 90-day mortality (3.2% vs 3.6% vs 4.9%, p < 0.001), and fewer margin positivity rates (14.4% vs 14.1% vs 17.8%; p < 0.001). Median length of stay was 5, 6, and 8 days for robotic, laparoscopic, and open, respectively (p < 0.001). Five-year overall survival was 56%, 54%, and 49%. On Cox regression adjusted for age, year, comorbidity, and stage, open APR was associated with a 25% higher hazard of all-cause mortality compared with robotic APR (HR 1.247, CI 1.061-1.466, p = 0.007), while laparoscopic and robotic demonstrated comparable survival. CONCLUSIONS: Minimally invasive APR for anal cancer has increased over time and is associated with shorter hospital stays, lower perioperative mortality, fewer positive margins, and improved survival. These findings support laparoscopic and robotic APR as preferred approaches for appropriately selected anal cancer patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Barekatain K, Simon EF, Tian S, et al. Robotic and laparoscopic abdominoperineal resections for anal cancer may improve outcomes compared with open surgery: insights from the National Cancer Database. Surg Endosc. 2026. PMID: 42230365. doi:10.1007/s00464-026-12925-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。